Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNGL
4601
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
| $3.11M | ﹤0.01% |
310,931
-1,126
| -0.4% | -$11.3K |
|
4602
Invesco Leisure and Entertainment ETF
PEJ
$314M
| $3.1M | ﹤0.01% |
85,513
+71,983
| +532% | +$3M |
|
|
LOGC
4603
CALL
DELISTED
ContextLogic
LOGC
| $3.1M | ﹤0.01% |
64,623
+7,936
| +14% | +$430K |
|
4604
Global X Uranium ETF
URA
$6.27B
| $3.1M | ﹤0.01% |
167,097
-125,647
| -43% | -$2.83M |
|
|
DOC
4605
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.1M | ﹤0.01% |
177,667
-130,644
| -42% | -$2.31M |
|
4606
TriCo Bancshares
TCBK
$1.84B
| $3.1M | ﹤0.01% |
67,909
-12,766
| -16% | -$538K |
|
|
MREO
4607
Mereo BioPharma
MREO
$50.9M
| $3.1M | ﹤0.01% |
2,763,425
-1,142,910
| -29% | -$886K |
|
4608
PUT
Darling Ingredients
DAR
$10.6B
| $3.09M | ﹤0.01% |
51,700
-50,000
| -49% | -$3.8M |
|
4609
Freedom 100 Emerging Markets ETF
FRDM
$3.43B
| $3.09M | ﹤0.01% |
+112,198
| New | +$3.46M |
|
4610
Golub Capital BDC
GBDC
$3.44B
| $3.09M | ﹤0.01% |
238,439
-415,556
| -64% | -$5.95M |
|
4611
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $3.09M | ﹤0.01% |
59,093
+26,236
| +80% | +$1.4M |
|
|
TUP
4612
DELISTED
Tupperware Brands Corporation
TUP
| $3.09M | ﹤0.01% |
487,343
+329,429
| +209% | +$3.68M |
|
|
NARI
4613
CALL
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.09M | ﹤0.01% |
45,400
+8,700
| +24% | +$625K |
|
4614
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $3.08M | ﹤0.01% |
+88,655
| New | +$3.38M |
|
4615
PUT
Valaris
VAL
$5.95B
| $3.08M | ﹤0.01% |
73,000
+14,300
| +24% | +$770K |
|
4616
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$744M
| $3.08M | ﹤0.01% |
147,536
+46,179
| +46% | +$1.03M |
|
4617
CALL
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $3.08M | ﹤0.01% |
62,800
+36,800
| +142% | +$1.9M |
|
4618
PUT
First Horizon
FHN
$12.4B
| $3.08M | ﹤0.01% |
140,900
-74,500
| -35% | -$1.67M |
|
4619
PUT
Frontline
FRO
$9.17B
| $3.08M | ﹤0.01% |
347,600
-300
| -0.1% | -$2.71K |
|
4620
CALL
Black Stone Minerals
BSM
$3.05B
| $3.08M | ﹤0.01% |
224,900
+146,300
| +186% | +$2.22M |
|
4621
VanEck Agribusiness ETF
MOO
$976M
| $3.08M | ﹤0.01% |
35,555
-691
| -2% | -$67.4K |
|
4622
Silgan Holdings
SLGN
$4.49B
| $3.07M | ﹤0.01% |
74,336
+42,971
| +137% | +$1.89M |
|
|
MOMO
4623
CALL
Hello Group
MOMO
$850M
| $3.07M | ﹤0.01% |
608,400
+376,200
| +162% | +$1.97M |
|
4624
MSCI
MSCI
$41.4B
| $3.07M | ﹤0.01% |
7,452
-141,573
| -95% | -$61.6M |
|
4625
Nuveen ESG US Aggregate Bond ETF
NUBD
$464M
| $3.07M | ﹤0.01% |
134,284
+115,537
| +616% | +$2.67M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.